Krystal Biotech (KRYS)

Krystal Biotech (KRYS) Balance Sheet


Krystal Biotech Balance Sheet

Krystal Biotech's total assets for Q4 2023 were $818.36M, an increase of 3.54% from the previous quarter. KRYS total liabilities were $39.71M for the fiscal quarter, a 15.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 818.36M$ 558.45M$ 626.29M$ 310.84M$ 209.02M
Total Liabilities
$ 39.71M$ 36.22M$ 32.72M$ 18.76M$ 6.11M
Total Equity Gross Minority
$ 778.67M$ 522.19M$ 593.58M$ 292.08M$ 202.91M
Total Capitalization
$ 785.26M$ 529.60M$ 593.58M$ 292.08M$ 202.91M
Preferred Stock Equity
Capital Lease Obligations
--$ 8.02M$ 11.55M$ 3.26M
Currency in USD

Krystal Biotech Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis